If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Company Also Introduces New U.S. Open Abdomen Management System Medical Guidelines SAN ANTONIO–(HSMN NewsFeed)–Kinetic Concepts, Inc. (NYSE: KCI ) will highlight the latest addition to the KCI Negative Pressure Technology Platform (NPTP), the ABThera…
Devices, Wound Care
Kinetic Concepts, Negative Pressure Wound Therapy, ABThera
Posts from ‘September, 2009’
KCI Highlights ABThera Open Abdomen Negative Pressure Therapy System at American Association for the Surgery of Trauma Conference Symposium
Cardo Lab Announces the Introduction and First Successful Implantation of the Align 360(TM) Total Knee System
LOS ANGELES, Sept. 30, 2009 –(HSMN NewsFeed) — Cardo Pharmaceutical (OTCBB:CDOM ), a company engaged in the development of orthopedic clinical devices, announces the introduction and first successful implantation of the Align 360(TM) Total Knee system. The initi…
Devices, Orthopaedic
Cardo Medical, Align 360, Total Knee, Uni-Compartmental
Aileron Appoints Industry Veteran Diane Jorkasky, M.D., as Company’s Head of Development and Chief Clinical Officer
R&D Leader Joins Aileron from Pfizer to Build Pipeline of Novel Stapled Peptide Drugs CAMBRIDGE, Mass., Sept., 30–(HSMN NewsFeed)–Aileron Therapeutics, a biotechnology company discovering and developing a novel class of therapeutics called Stapled Pep…
Biopharmaceuticals, Personnel
Aileron Therapeutics
Mylan Receives FDA Approval for Generic Version of Parkinson’s Treatment Sinemet(R)
PITTSBURGH, Sept. 30 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ca…
Biopharmaceuticals, Generics, Neurology, FDA
Mylan, Mylan Pharmaceuticals, Carbidopa, Levodopa, Sinemet
New Medical Data Shows AMS’ Minimally Invasive Treatment Options Effective at Restoring Female Pelvic Health
Three New Studies Indicate High Degree of Efficacy and Patient Satisfaction with Minimal Pain and Adverse Events for Stress Urinary Incontinence and Vaginal Prolapse Treatment Systems MINNETONKA, Minn., Sept., 29–(HSMN NewsFeed)–American Pharmaceutical Syste…
Devices
American Clinical Systems Holdings, MiniArc Sling System
Ardian(R) Demonstrates Durable Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM)
PALO ALTO, Calif., Sept. 20 five (HSMN NewsFeed) — Data supporting the long-term safety and effectiveness of renal sympathetic denervation (RDN) in treating patients with chronic hypertension were presented today at the Transcatheter Cardiovascular Therapeut…
Devcies, Cardiology
Ardian Inc, renal sympathetic denervation, Symplicity Catheter
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
NATICK, Mass. and SAN FRANCISCO, Sept. 25 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) today announced two-year follow-up data from the HORIZONS-AMI trial. The trial, sponsored by the Cardiovascular Research Foundation (CRF) with grant s…
Devices, Interventional Cardiology
Boston Scientific, HORIZONS-AMI, TAXUS Express2, drug eluting stent
Positron Anticipates Cardiac PET Demand to Increase Due to Expanding Reimbursment Differential Between PET and SPECT Imaging
INDIANAPOLIS–(HSMN NewsFeed)–Positron Corporation (OTCBB:POSC ) a molecular imaging solutions company focused on Nuclear Cardiology, predicts a significant rise in demand for Cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46% and an in…
Devices, Radiology, Cardiology
Positron Corp, Positron Emission Tomography
Calypte Biomedical Announces Changes to its Board of Directors
PORTLAND, Ore.–(HSMN NewsFeed)–Calypte Biomedical Corporation (OTCBB:CBMC ), a developer, manufacturer and marketer of HIV diagnostic tests, announces changes to its board of directors. On September 16, 2009, Calypte reported that Julius R. Krevans, M…
Diagnostics, HIV/AIDS, Personnel
Calypte Biomedical
Frances D. Fergusson And John P. Mascotte Elected To Pfizer’s Board Of Directors
NEW YORK–(HSMN NewsFeed)–Pfizer Inc today announced the election of Frances D. Fergusson, Ph.D. and John P. Mascotte to its Board of Directors. Dr. Fergusson and Mr. Mascotte, current members of the Board of Directors of Wyeth, will join the Pfizer Board…
Biopharmaceuticals, Personnel
Pfizer
